Prometic Life Sciences Inc.

ProMetic is a biopharmaceutical corporation with globally recognized expertise in bioseparation and uses its own affinity technology for the development of best in class plasma-derived therapeutics. ProMetic is also active in developing its own novel small molecule therapeutics products.

Headquartered in Laval, Canada, ProMetic has a global presence through its various sites in the UK and USA, providing both manufacturing and R&D capability. These strategic locations facilitate ProMetic’s growth globally and supports all business activity in American, European and Asian markets.

ProMetic is publicly traded on TSX (Symbol: PLI) and OTCQX (Symbol: PFSCF).

ProMetic has developed core competencies in strategic fields, including:

  • Purification of biologics
  • Drug development
  • Proteomics
  • Elimination of pathogens

The business is now focused on developing its range of therapeutics from both its plasma-derived and small-molecule platform.

Read More